The country's biggest gas-compression fleet has the cleanest rating sheet of
the year


 
<[link removed]> 



You are receiving this email because you are subscribed to Daily Wall Street
Alerts, a publication from Behind the Markets. If you no longer wish to receive
these emails, pleaseunsubscribe
<[link removed]>
here.




LEAD STORY

<[link removed]>
15 Analysts. 15 Buys.
<[link removed]>

Pull up any stock’s research page and you’ll find what we call the nouns.
Fourteen analysts. Consensus: Strong Buy. Average target: $50. Tidy, official,
permanent-looking. Here’s what the page doesn’t tell you: a rating keeps voting
whether anyone’s touched it or not. An analyst sets a Buy, moves on to the
other twenty companies he covers, and may not seriously revisit yours for
months. His Buy still counts in the tally. His old target still pulls the
average. A rating is like the “Best Diner in Town” sticker on the window — it
stays up long after the critic stopped coming in. Over the past three
Wednesdays we’ve counted the bench, watched which way the estimates move, and
read the spread and the floor. Tonight, the tool that ties them together:
ignore the nouns. Read the verbs — and check their dates. Tonight: three
profitable, growing companies rated Buy or better by nearly every firm covering
them, with gaps of roughly 30%, 37%, and 37% to their average targets — and
each one is a…
READ FULL ARTICLE →
<[link removed]>



FEATURED ANALYSIS


AI’s Power Bill, Biotech’s Binary Bet
<[link removed]>

The market keeps presenting AI as a software story. That is convenient for the
people selling the story. The actual buildout is more physical: chips,
networking, optical links, servers, power, cooling, and storage. Biotech has
the opposite problem. The science can be extraordinary, but the investment
outcome may still turn on a trial endpoint, a regulator’s decision, or a
financing runway. We want both themes in the portfolio conversation, but we are
not going to pretend they carry the same…
READ FULL ARTICLE →
<[link removed]>




MORE HEADLINES


1. Wall Street's Estimate for Walmart Sits Exactly on Top of Walmart's Own
Guidance. Last Time That Happened, the Stock Fell 4%.
<[link removed]>
2. Cisco Just Finished the Best Year in Its History and Guided $1.3 Billion
Above Estimates. The Stock Fell 10%.
<[link removed]>
3. CoreWeave's Revenue Doubled and the Stock Jumped 21%. Its Debt Grew by $12
Billion in Three Months.
<[link removed]>
4. The Biggest Threat to Your Portfolio Isn't Iran
<[link removed]>


 



Behind the Markets · Text Alerts



Stay Ahead of the Market



The best investment opportunities don't wait. Get our research and stock ideas
delivered straight to your smartphone—so you never miss a market-moving
opportunity. Our text alerts ensure you see timely stock ideas and professional
research reports instantly, whether you're in a meeting, commuting, or away
from your desk.

GET TEXT ALERTS FROM BEHIND THE MARKETS (FREE) →
<[link removed]>

 

 
<[link removed]>

YOUR DAILY MARKET INTELLIGENCE



You're receiving this because you signed up for the Daily Wall Street Alerts
newsletter.

Daily Wall Street Alerts is a Behind the Markets <[link removed]>
Publication.
Behind the Markets, LLC
4260 NW 1st Ave #55, Boca Raton, FL 33431




Unsubscribe
<[link removed]>


Terms of Use <[link removed]>


Privacy Policy <[link removed]>






© 2026 Behind the Markets. All rights reserved.